ArticleAntimicrobial agents and chemotherapy2018

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.

Ryan K Shields et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.